Lenvatinib plus Pembrolizumab Combination Therapy for Advanced or Recurrent Endometrial Cancer: A Single-Center, Retrospective Analysis

Tohoku J Exp Med. 2023 Nov 23. doi: 10.1620/tjem.2023.J095. Online ahead of print.NO ABSTRACTPMID:38008437 | DOI:10.1620/tjem.2023.J095

Source: The Tohoku Journal of Experimental Medicine - November 26, 2023 Category: Research Authors: Mikako Tochigi Shogo Shigeta Muneaki Shimada Shuko Miyahara Junko Hasegawa-Minato Yusuke Shibuya Masumi Ishibashi Chiaki Hashimoto Hideki Tokunaga Nobuo Yaegashi Source Type: research